Poplar Healthcare, a Memphis-based laboratory services company founded in 1995, has completed the acquisition of substantially all of the assets of Bostwick Laboratories, a specialty anatomic pathology laboratory focused on the diagnosis of cancer.
Bostwick Laboratories is a leader in urologic pathology with expertise and a growing presence in the dermatology, gastroenterology, gynecology, and nephrology sectors of the anatomic pathology market. Poplar Healthcare has acquired the operating assets of Bostwick Laboratories including the customers, inventory, and equipment at Bostwick Laboratories facilities in Uniondale, New York; Orlando, Florida; and Glen Allen, Virginia.
Through this transaction, Bostwick Laboratories will gain access to additional markets and health plans. As an in-network laboratory service provider to most major insurance carriers and health plans, Poplar Healthcare will provide expanded access to Bostwick Laboratories’ patients. Bostwick customers will receive access to an expanded menu of tests and services via Poplar Healthcare’s extensive menu of molecular testing services which will be available through Bostwick Laboratories. In addition, Poplar Healthcare will gain a leading renal pathology laboratory and additional sub-specialized pathologists.
Poplar Healthcare provides specialized laboratory testing services to a nationwide client base of gastroenterologists, dermatologists, oncologists, urologists, gynecologists and their patients.